measles mumps rubella vaccine

Summary

Summary: A combined vaccine used to prevent MEASLES; MUMPS; and RUBELLA.

Top Publications

  1. ncbi Taking a closer look: an examination of measles, mumps, and rubella immunization uptake in Saskatoon
    Kyla Avis
    College of Nursing, University of Saskatchewan, Saskatoon, SK
    Can J Public Health 98:417-21. 2007
  2. ncbi MMR vaccine uptake rates: a data validation study
    S Ghebrehewet
    Communicable Disease Unit, Countess of Chester Health Park, Cheshire and Merseyside Health Protection Team, Public Health Laboratory, Liverpool Road, Chester CH2 1UL
    Commun Dis Public Health 6:144-6. 2003
  3. ncbi [Using surveys of schoolchildren to evaluate coverage with and opportunity for vaccination in Costa Rica]
    Nidia Calvo
    Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud INCIENSA, Tres Rios, Costa Rica
    Rev Panam Salud Publica 16:118-24. 2004
  4. ncbi Safety concerns regarding combination vaccines: the experience in Japan
    Margie C Andreae
    CHEAR Child Health Evaluation and Research Unit, University of Michigan, Ann Arbor, MI 48109 0456, USA
    Vaccine 22:3911-6. 2004
  5. ncbi Susceptibility of medical students to vaccine-preventable viral diseases: a serological study
    Junko Kukino
    Department of General Medicine, Juntendo University School of Medicine, 2 1 1 Bunkyo ku, Tokyo 113 8421, Japan
    J Infect Chemother 10:335-7. 2004
  6. pmc The seroepidemiology of measles in Western Europe
    H de Melker
    National Institute of Public Health and the Environment, Bilthoven, The Netherlands
    Epidemiol Infect 126:249-59. 2001
  7. ncbi Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance
    R G Pebody
    Sero Epidemiology Unit, Immunisation Division, PHLS Communicable Disease Surveillance Centre, 61 Colindale Avenue, London, UK
    Vaccine 20:1134-40. 2002
  8. ncbi Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up
    A Patja
    Hospital for Children and Adolescents, Helsinki University Central Hospital, Finland
    Pediatr Infect Dis J 19:1127-34. 2000
  9. ncbi Accuracy of routine data on MMR vaccination coverage and validity of parental recall of vaccination
    G Lyratzopoulos
    Commun Dis Public Health 5:305-10. 2002
  10. pmc Parents' perspectives on the MMR immunisation: a focus group study
    M Evans
    Division of Primary Health Care, University of Bristol
    Br J Gen Pract 51:904-10. 2001

Research Grants

Detail Information

Publications223 found, 100 shown here

  1. ncbi Taking a closer look: an examination of measles, mumps, and rubella immunization uptake in Saskatoon
    Kyla Avis
    College of Nursing, University of Saskatchewan, Saskatoon, SK
    Can J Public Health 98:417-21. 2007
    ....
  2. ncbi MMR vaccine uptake rates: a data validation study
    S Ghebrehewet
    Communicable Disease Unit, Countess of Chester Health Park, Cheshire and Merseyside Health Protection Team, Public Health Laboratory, Liverpool Road, Chester CH2 1UL
    Commun Dis Public Health 6:144-6. 2003
    ..Electronic transfer of information from practices to the CHCS and between CHCSs, i.e. across boundaries, could improve data accuracy...
  3. ncbi [Using surveys of schoolchildren to evaluate coverage with and opportunity for vaccination in Costa Rica]
    Nidia Calvo
    Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud INCIENSA, Tres Rios, Costa Rica
    Rev Panam Salud Publica 16:118-24. 2004
    ....
  4. ncbi Safety concerns regarding combination vaccines: the experience in Japan
    Margie C Andreae
    CHEAR Child Health Evaluation and Research Unit, University of Michigan, Ann Arbor, MI 48109 0456, USA
    Vaccine 22:3911-6. 2004
    ....
  5. ncbi Susceptibility of medical students to vaccine-preventable viral diseases: a serological study
    Junko Kukino
    Department of General Medicine, Juntendo University School of Medicine, 2 1 1 Bunkyo ku, Tokyo 113 8421, Japan
    J Infect Chemother 10:335-7. 2004
    ..A weak correlation was observed among antibody titers for measles, rubella, and mumps but not for varicella. These results suggest that MMR vaccine might be effective in people with low levels of antibody to measles, rubella, and mumps...
  6. pmc The seroepidemiology of measles in Western Europe
    H de Melker
    National Institute of Public Health and the Environment, Bilthoven, The Netherlands
    Epidemiol Infect 126:249-59. 2001
    ..In the high susceptibility country the priority will be to increase infant vaccine coverage and reduce regional variation in coverage levels...
  7. ncbi Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance
    R G Pebody
    Sero Epidemiology Unit, Immunisation Division, PHLS Communicable Disease Surveillance Centre, 61 Colindale Avenue, London, UK
    Vaccine 20:1134-40. 2002
    ..Further studies including qualitative measures, such as avidity, in different populations are merited and may contribute to the understanding of MMR population protection...
  8. ncbi Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up
    A Patja
    Hospital for Children and Adolescents, Helsinki University Central Hospital, Finland
    Pediatr Infect Dis J 19:1127-34. 2000
    ..Several disorders have been attributed to measles-mumps-rubella (MMR) vaccination during the past decade. The aim of this prospective follow-up study was to identify serious adverse events causally related to MMR vaccination...
  9. ncbi Accuracy of routine data on MMR vaccination coverage and validity of parental recall of vaccination
    G Lyratzopoulos
    Commun Dis Public Health 5:305-10. 2002
    ..Routine data may modestly underestimate vaccination coverage and significantly overestimate measles susceptibility. Many parents of MMR unvaccinated children believe that their children have been vaccinated...
  10. pmc Parents' perspectives on the MMR immunisation: a focus group study
    M Evans
    Division of Primary Health Care, University of Bristol
    Br J Gen Pract 51:904-10. 2001
    ..We need to understand what influences parents' decisions on whether to accept MMR or not so that health professionals can provide a service responsive to their needs...
  11. ncbi The effectiveness of the mumps component of the MMR vaccine: a case control study
    Richard Harling
    HPA CDSC, 61 Colindale Avenue, London NW9 5EQ, UK
    Vaccine 23:4070-4. 2005
    ..Two doses of vaccine were more effective (88% (95% CI: 62-96%)) than a single dose (64% (95% CI: 40-78%)). The current two-dose vaccination programme remains the best method for controlling mumps infection in the community...
  12. ncbi A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia
    Heath Kelly
    Victorian Infectious Diseases Reference Laboratory, Locked Bag 815, 10 Wreckyn Street, North Melbourne 3051, Carlton South, VIC 3053, Australia
    Vaccine 20:3130-6. 2002
    ....
  13. pmc Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionals
    M Petrovic
    Department of Public Health, North Wales Health Authority, Preswylfa, Mold, Flintshire CH7 1PZ, UK
    BMJ 322:82-85. 2001
    ..To determine the knowledge, attitudes, and practices among health professionals regarding the measles, mumps, and rubella (MMR) vaccine, particularly the second dose...
  14. pmc Communication and miscommunication of risk: understanding UK parents' attitudes to combined MMR vaccination
    Paul Bellaby
    Institute for Public Health Research and Policy, University of Salford, Greater Manchester M5 4QA
    BMJ 327:725-8. 2003
  15. ncbi Accelerated rubella control and congenital rubella syndrome prevention strengthen measles eradication: the Costa Rican experience
    Ana Morice
    Ministry of Health, San Jose, Costa Rica
    J Infect Dis 187:S158-63. 2003
    ..Targeting MR vaccination appropriately and using the opportunity to strengthen surveillance for rash illness has benefits beyond accelerated rubella control and CRS prevention, including strengthening of the measles eradication program...
  16. ncbi Evolution of surveillance of measles, mumps, and rubella in England and Wales: providing the platform for evidence-based vaccination policy
    A J Vyse
    PHLS Communicable Disease Surveillance Centre, 61 Colindale Avenue, London NW9 5EQ, United Kingdom
    Epidemiol Rev 24:125-36. 2002
  17. ncbi Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children
    Henry R Shinefield
    Kaiser Permanente Vaccine Study Group, Oakland, CA 94612, USA
    Pediatr Infect Dis J 21:555-61. 2002
    ....
  18. pmc Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century
    A J Vyse
    Health Protection Agency, Centre for Infections, Sero Epidemiology Unit, Immunisation Department, London, UK
    Epidemiol Infect 134:1303-12. 2006
    ..Investigations into the efficacy of two doses of a mumps containing vaccine should be a priority during the current epidemic...
  19. pmc MMR uptake data are unlikely to be subject to manipulation
    Mary Ramsay
    BMJ 324:1394. 2002
  20. pmc Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study
    Brent Taylor
    Centre for Community Child Health, Royal Free and University College Medical School, University College London Royal Free Campus, London
    BMJ 324:393-6. 2002
    ..To investigate whether measles, mumps, and rubella (MMR) vaccination is associated with bowel problems and developmental regression in children with autism, looking for evidence of a "new variant" form of autism...
  21. ncbi Sero-epidemiology of measles and mumps in Korea: impact of the catch-up campaign on measles immunity
    Sung Soo Kim
    Department of Biomedical Sciences, National Institute of Health, 5 Nokbun dong, Eunpyung Gu, Seoul 122 701, South Korea
    Vaccine 23:290-7. 2004
    ..Furthermore, our results suggest continuous mumps outbreaks could occur because of the accumulation of susceptible individuals...
  22. pmc Measles in the United Kingdom: can we eradicate it by 2010?
    Perviz Asaria
    Infection and Immunology Delivery Unit, Guy s and St Thomas s NHS Foundation Trust, St Thomas s Hospital, London SE1 7EH
    BMJ 333:890-5. 2006
  23. ncbi Measles control in NSW divisions of general practice
    C Raina MacIntyre
    National Centre for Immunisation Research, The University of Sydney and The Children s Hospital at Westmead
    N S W Public Health Bull 14:13-7. 2003
  24. ncbi Sustained measles elimination in Australia and priorities for long term maintenance
    Heather F Gidding
    Centre for Infectious Diseases and Microbiology CIDM Public Health, ICPMR Building, 3rd Floor, Westmead Hospital, Westmead, and the University of Sydney, NSW, Australia
    Vaccine 25:3574-80. 2007
    ..This experience is likely to apply to developed countries that have achieved or are approaching measles elimination...
  25. ncbi The MMR vaccination and autism controversy in United Kingdom 1998-2005: inevitable community outrage or a failure of risk communication?
    David C Burgess
    NHMRC Clinical Trials Centre, The University of Sydney, Sydney NSW 2006, Australia
    Vaccine 24:3921-8. 2006
    ..Coverage rates fell dramatically, and did not start to recover until 2004. Could this public reaction have been predicted?..
  26. ncbi Outbreak of mumps in a vaccinated child population: a question of vaccine failure?
    Corinne Vandermeulen
    Department of Youth Health Care, Katholieke Universiteit Leuven, Kapucijnenvoer 35 1, 3000, Belgium
    Vaccine 22:2713-6. 2004
    ..The role of secondary vaccine failure is highlighted...
  27. ncbi 'Between the demands of truth and government': health practitioners, trust and immunisation work
    Julie Brownlie
    Department of Applied Social Science, Stirling University, Colin Bell Building, UK
    Soc Sci Med 62:433-43. 2006
    ....
  28. ncbi Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts
    I Davidkin
    National Public Health Institute, Helsinki, Finland
    Vaccine 16:2052-7. 1998
    ..It is important to follow how long the protection achieved by the present vaccine programme will last after elimination of indigenous measles...
  29. pmc Effect of Pentavac and measles-mumps-rubella (MMR) vaccination on the intestine
    B Thjodleifsson
    Department of Medicine, University Hospital, Hringbraut, Reykjavik, Iceland
    Gut 51:816-7. 2002
    ..In particular it has been suggested that the measles, mumps, and rubella (MMR) vaccination leads to brain damage manifesting as autism consequent to the development of an "enterocolitis" in the immediate post-vaccination period...
  30. ncbi Misleading media reporting? The MMR story
    Justin Lewis
    School of Journalism, Media and Cultural Studies, Cardiff University, UK
    Nat Rev Immunol 3:913-8. 2003
  31. pmc Misled and confused? Telling the public about MMR vaccine safety. Measles, mumps, and rubella
    C J Clements
    Department of Vaccines and Biologicals, World Health Organization, Geneva, Switzerland
    J Med Ethics 29:22-6. 2003
    ....
  32. ncbi The vaccines for children program. Policies, satisfaction, and vaccine delivery
    R K Zimmerman
    Department of Family Medicine and Clinical Epidemiology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA
    Am J Prev Med 21:243-9. 2001
    ..Characterize the Vaccines for Children (VFC) programs in Minnesota and Pennsylvania, assess providers' satisfaction with each state's program, and examine changes in doses administered in the public sector since implementation of the VFC...
  33. ncbi A mathematical model to measure the impact of the Measles Control Campaign on the potential for measles transmission in Australia
    C R Macintyre
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The New Children s Hospital, Westmead, NSW, Australia
    Int J Infect Dis 6:277-82. 2002
    ....
  34. ncbi A new measles mumps rubella (MMR) vaccine: a randomized comparative trial for assessing the reactogenicity and immunogenicity of three consecutive production lots and comparison with a widely used MMR vaccine in measles primed children
    Chin Yun Lee
    Department of Pediatrics, National Taiwan University Hospital, Taipei
    Int J Infect Dis 6:202-9. 2002
    ....
  35. ncbi Combination vaccine use and vaccination quality in a managed care population
    Laura E Happe
    Xcenda, Palm Harbor, FL 34685, USA
    Am J Manag Care 13:506-12. 2007
    ..To evaluate the impact of a pentavalent combination vaccine on childhood immunization coverage rates and timeliness within a managed care organization...
  36. ncbi [Issues related to rubella, measles and epidemic parotiditis in the Russian Federation]
    V V Zverev
    Vopr Virusol 49:8-11. 2004
    ....
  37. ncbi Varicella vaccines and measles, mumps, rubella, and varicella vaccine
    Lucia Ferro Bricks
    Departamento de Pediatria, Faculdade de Medicina da Universidade de São Paulo USP, Sao Paulo, SP, Brazil
    J Pediatr (Rio J) 82:S101-8. 2006
    ..To present an up-to-date review of studies investigating the efficacy, adverse events and vaccination regimens of the varicella vaccine and the new presentation combined with the vaccine for measles, mumps and rubella...
  38. ncbi Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey
    C Amela
    National Centrefor Epidemiology, Carlos III Institute of Public Health, Madrid, Spain
    Eur J Epidemiol 18:71-9. 2003
    ..A possible explanation for the higher susceptibility observed for mumps might lie in the Rubini strain's low efficacy...
  39. ncbi Risk factors for undervaccination against measles in a large sample of preschool children from rural Bavaria
    A P Zucs
    Postgraduate Program in Public Health, Ludwig Maximilian University School of Medicine, Marchioninistrasse 15, D 81377 Munich, Germany
    Infection 32:127-33. 2004
    ..Due to insufficient vaccination rates, measles outbreaks still pose a threat to public health in Germany. The purpose of this study was to identify risk factors for undervaccination against measles...
  40. pmc Ethnicity as a correlate of the uptake of the first dose of mumps, measles and rubella vaccine
    Ruth E Mixer
    Postgraduate Education Centre, Charing Cross Hospital, Fulham Palace Road, Hammersmith, London, UK
    J Epidemiol Community Health 61:797-801. 2007
    ..An important association between ethnicity and uptake of MMR1 vaccine is observed. This has implications for efforts to improve the currently inadequate levels of MMR vaccination across the population as a whole...
  41. pmc Epidemiology of measles, mumps and rubella in Italy
    G Gabutti
    Department of Health Sciences, Hygiene and Preventive Medicine Section, Faculty of Medicine, University of Genoa, Italy
    Epidemiol Infect 129:543-50. 2002
    ....
  42. ncbi [The knowledge about measles, mumps and rubella among parents in the county of Roskilde]
    Lars Folmer Hansen
    Børneafdeling, Amtssygehuset Roskilde
    Ugeskr Laeger 164:5748-52. 2002
    ..The aim was to determine how much knowledge parents have of MMR diseases and the side effects of the vaccine, and what influence this has on acceptance of the vaccination programme...
  43. ncbi Global measles elimination efforts: the significance of measles elimination in the United States
    Peter M Strebel
    Global Immunization Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 189:S251-7. 2004
    ..This experience provides evidence that sustained interruption of transmission can be achieved in large geographic areas, suggesting the feasibility of global eradication of measles...
  44. ncbi [Vaccination against rubella, measles, chickenpox, and mumps in nursing students]
    Takayoshi Tashiro
    Department of Nursing, Nagasaki University School of Health Sciences
    Kansenshogaku Zasshi 78:398-403. 2004
    ..6% in measles, 48.0% in chickenpox, 93.8% in mumps, respectively. Susceptible nursing students, as well as the medical stuff, should be vaccinated in order to prevent hospital infection of rubella, measles, chickenpox, and mumps...
  45. ncbi An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States
    Fangjun Zhou
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 189:S131-45. 2004
    ..From both perspectives under even the most conservative assumptions, the national 2-dose MMR vaccination program is highly cost-beneficial and results in substantial cost savings...
  46. ncbi Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy
    R Sultana
    Department of Immunology, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders BIRDEM, Dhaka, Bangladesh
    Scand J Immunol 64:684-9. 2006
    ....
  47. ncbi Immediate injection pain in infants aged 18 months during vaccination against measles, mumps and rubella with either Priorix or MMR-II
    Nina Knutsson
    Primary Health and Medical Care, Child Health Centre, Munkebäckstorg, S 416 73 Göteborg, Sweden
    Vaccine 24:5800-5. 2006
    ..Mean VAS value was 2.3/5.2 for Priorix and MMR-II, respectively (p<0.001). Mean CHEOPS value was 1.9/6.1 for Priorix and MMR-II, respectively (p<0.001). The study shows that Priorix gives less immediate injection pain than MMR-II...
  48. ncbi [35-year measles, mumps, rubella vaccination assessment in France]
    P Reinert
    Service de Pediatrie, Centre Hospitalier Intercommunal de Creteil, 40 rue de Verdun, 94010, Creteil, France
    Arch Pediatr 10:948-54. 2003
    ....
  49. ncbi [The triple virus vaccine: old viruses, new problems]
    Fernando de Ory
    Enferm Infecc Microbiol Clin 25:227-9. 2007
  50. pmc Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study
    J Mossong
    Laboratoire National de Santé, PO Box, 1102, L 1011 Luxembourg
    Epidemiol Infect 132:11-8. 2004
    ..Present vaccination coverage with MMR appears to be sufficient to prevent large local outbreaks of measles and rubella, but probably not mumps...
  51. ncbi Why do parents hesitate to vaccinate their children against measles, mumps and rubella?
    R Alfredsson
    Department of Paediatrics, Institution of Women s and Children s health, Goteborg University, Goteborg, Sweden
    Acta Paediatr 93:1232-7. 2004
    ..Coverage among children 18 mo of age has been 99%, but the measles, mumps and rubella vaccination (MMR) has increasingly been questioned among parents...
  52. ncbi Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age
    Stephen C Redd
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 189:S116-22. 2004
    ..The response to mumps varied little by age of the child or birth year of the child's mother. These results support the recommended age for first vaccination with measles-mumps-rubella at 12-15 months...
  53. ncbi Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy
    Matteo Zignol
    Department of Pediatrics, Faculty of Medicine and Surgery, University of Padua, Padua, Italy
    Cancer 101:635-41. 2004
    ....
  54. ncbi Assessment of the potency and potential immunomodulatory effects of the measles mumps rubella and varicella vaccine in infants
    Stephanie T Yerkovich
    Telethon Institute for Child Health Research, and Centre for Child Health Research, Faculty of Medicine and Dentistry, The University of Western Australia, Perth, WA, Australia
    Vaccine 25:1764-70. 2007
    ..Parallel analyses of cytokine responses to phytohaemagglutinin and tetanus toxoid did not detect any "bystander" effects of the vaccines on systemic immunity...
  55. pmc The contribution of single antigen measles, mumps and rubella vaccines to immunity to these infections in England and Wales
    Pam Sonnenberg
    Immunisation Department, Centre for Infections, Health Protection Agency, London, UK
    Arch Dis Child 92:786-9. 2007
    ..To obtain information on the use of single antigen measles, mumps and rubella vaccines to improve estimates of population immunity and help predict outbreaks...
  56. ncbi Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants
    V Spoulou
    Department of Pediatrics, Athens University School of Medicine, Greece
    Bone Marrow Transplant 33:1187-90. 2004
    ..We conclude that a single dose of MMR given at 2 years after BMT induces suboptimal and short-lived immune responses to measles and mumps; a second dose should be recommended for paediatric BMT recipients...
  57. ncbi MMR debate fall-out continues
    Rachael Paterson
    Lancet Infect Dis 4:653. 2004
  58. ncbi MMR vaccination: new thought
    Vinayak Deshmukh
    Indian Pediatr 43:555-6. 2006
  59. ncbi Feeling bad about immunising our children
    Abigail L Wroe
    Department of Psychology, Institute of Psychiatry, Kings College London, De Crespigny Park, Denmark Hill, London SE5 8AF, UK
    Vaccine 23:1428-33. 2005
    ....
  60. ncbi Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens
    Anna Nilsson
    Pediatric Cancer Research Unit, Astrid Lindgren Children Hospital, Stockholm, Sweden
    Pediatrics 109:e91. 2002
    ....
  61. ncbi A combination vaccine against measles, mumps, rubella and varicella
    Markus Knuf
    Pediatric University Hospital, Johannes Gutenberg University, Mainz, Germany
    Drugs Today (Barc) 44:279-92. 2008
    ..For other countries considering introducing these vaccines, the advantages for children, parents and healthcare providers of protecting against four diseases in a single vaccine should be noted...
  62. ncbi Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life
    Volker Schuster
    Hospital for Children and Adolescents, University of Leipzig, Leipzig, Germany
    Pediatr Infect Dis J 27:724-30. 2008
    ..This study (104389/NCT00127023) was undertaken to assess the immunogenicity and safety of a new refrigerator-stable tetravalent MMRV vaccine after 1 dose and after 2 doses administered during the second year of life...
  63. ncbi Serosurvey of measles, mumps and rubella antibodies in Saudi children
    Yagob Y Al-Mazrou
    Department of Preventive Medicine, MOH, Riyadh, Kingdom of Saudi Arabia
    Saudi Med J 26:1551-4. 2005
    ..A serosurvey study to evaluate the proportion of children with antibodies against diseases targeted by the Expanded Program of Immunization in the Kingdom of Saudi Arabia...
  64. ncbi Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy
    Francesca Fioredda
    Cancer 103:1758-9; author reply 1760. 2005
  65. ncbi Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy
    Hans Jürgen Laws
    Cancer 103:1759; author reply 1760. 2005
  66. ncbi Live virus immunization after orthotopic liver transplantation
    Saba Khan
    Department of Pediatrics, Children s Hospital of Philadelphia, Philadelphia, PA 19104, USA
    Pediatr Transplant 10:78-82. 2006
    ..Only minor adverse effects reported in the general population were observed. Live virus immunization with MMR and Varivax was safe and immunogenic in this selected population of liver transplant recipients...
  67. ncbi Rubella, rubeola, and mumps in pregnant women: susceptibilities and strategies for testing and vaccinating
    David M Haas
    Department of Obstetrics and Gynecology, Naval Hospital Camp Lejeune, Jacksonville, North Carolina 28547, USA
    Obstet Gynecol 106:295-300. 2005
    ..A secondary objective was to assess costs of vaccination and testing programs aimed at eliminating these viral susceptibilities to determine an optimal strategy...
  68. ncbi Postlicensure epidemiology of childhood vaccination: the Danish experience
    Anders Hviid
    Statens Serum Institut, Department of Epidemiology Research, Artillerivej 5, 2300 Copenhagen S, Denmark
    Expert Rev Vaccines 5:641-9. 2006
    ....
  69. ncbi Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children
    Cornelia Feiterna-Sperling
    Charite University Medicine Berlin, Berlin, Germany
    Pediatr Infect Dis J 24:1083-8. 2005
    ..This study compared the immunogenicity and safety of MMR Berna, which is produced entirely in human diploid cells, with those of the licensed vaccine M-M-RVax (Merck & Co.)...
  70. ncbi Humoral and cellular immune response after measles vaccination in Taiwan
    Chou Lang Huang
    Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan
    J Microbiol Immunol Infect 38:169-75. 2005
    ....
  71. ncbi The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody
    Jay M Lieberman
    Miller Children s Hospital, UCLA Center for Vaccine Research, Long Beach, CA 90806, USA
    Pediatr Infect Dis J 25:615-22. 2006
    ..An additional objective was to evaluate the persistence of antibodies 1 year postvaccination...
  72. ncbi A new challenge for Europe: introducing a pediatric quadrivalent vaccine for measles, mumps, rubella, and varicella
    Jose Ramet
    Department of Pediatrics, Universitair Ziekenhuis Antwerpen, Antwerp Belgium
    Int J Infect Dis 11:S49-55. 2007
    ..Varicella is often considered to be a benign disease of childhood. In fact, varicella is associated with serious complications and mortality even among healthy individuals...
  73. ncbi [Post-transplantation vaccination of bone-marrow transplant recipients]
    Carmen Adell
    Centro de Vacunación de Adultos Servicio de Medicina Preventiva UASP IDIBAPS Hospital Clínic Barcelona España
    Med Clin (Barc) 119:405-9. 2002
    ..The objective of this study was to determine the susceptibility to vaccine-preventable diseases in people subject to BMT and the serologic response after vaccination...
  74. ncbi Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003
    Armenak Asatryan
    Science Applications International Corporation and Emory University School of Medicine, Atlanta, GA, USA
    Vaccine 26:1166-72. 2008
    ..Thus, HL following MMCV has been reported in the literature and to the VAERS. Further studies are needed to better understand if there is a causal relationship between MMCV and HL...
  75. ncbi Pediatric sentinel surveillance of vaccine-preventable diseases in Italy
    Marta Luisa Ciofi degli Atti
    Laboratorio di Epidemiologia e Biostatistica, Istituto Superiore di Sanita, Rome, Italy
    Pediatr Infect Dis J 21:763-8. 2002
    ..In January, 2000, a pediatric sentinel network was launched, with the aim of monitoring in a timely and accurate way the geographic and temporal trends of vaccine-preventable diseases...
  76. pmc Reliability of medical students' vaccination histories for immunisable diseases
    Sabine Wicker
    Occupational Health Service, Hospital of the Johann Wolfgang Goethe University of Frankfurt, Theodor Stern Kai 7, 60590 Frankfurt, Germany
    BMC Public Health 8:121. 2008
    ..Medical students come into contact with infectious diseases early on their career. Immunity against vaccine-preventable diseases is therefore vital for both medical students and the patients with whom they come into contact...
  77. ncbi [Seroprevalence of measles antibody and its attributable factors in elementary students of routine 2-dose schedule era with vaccination record]
    Geun Ryang Bae
    Department of Preventive Medicine, College of Medicine, Dongguk University
    J Prev Med Public Health 38:431-6. 2005
    ..We investigated the seroprevalence of the measles antibody and its attributable factors for the students who underwent routine 2-dose Schedule Era...
  78. ncbi Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States
    Vitali Pool
    Vaccine Safety and Development Activity, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Pediatrics 110:e71. 2002
    ....
  79. ncbi Antibody responses of healthy infants to concurrent administration of a bivalent haemophilus influenzae type b-hepatitis B vaccine with diphtheria-tetanus-pertussis, polio and measles-mumps-rubella vaccines
    D J West
    BioDrugs 15:413-8. 2001
    ....
  80. ncbi Impact of a decline in Colorado Medicaid managed care enrollment on access and quality of preventive primary care services
    Stephen Berman
    Department of Pediatrics, University of Colorado School of Medicine, Denver, Colorado, USA
    Pediatrics 116:1474-9. 2005
    ..5% to 25.3%. This shift of children from HMO managed care to the UFFS program provided a natural experiment to assess the impact of not having an assigned PCP on pediatric primary care services...
  81. ncbi The association between having a medical home and vaccination coverage among children eligible for the vaccines for children program
    Philip J Smith
    Centers for Disease Control and Prevention, National Immunization Program, MS E 32, 1600 Clifton Rd, NE, Atlanta, GA 30333, USA
    Pediatrics 116:130-9. 2005
    ..A desired consequence of the program is to promote comprehensive continuous medical care within a medical home for these children...
  82. ncbi Safety, tolerability and immunogenicity of concomitant injections in separate locations of M-M-R II, VARIVAX and TETRAMUNE in healthy children vs. concomitant injections of M-M-R II and TETRAMUNE followed six weeks later by VARIVAX
    H R Shinefield
    Kaiser Permanente Vaccine Study Center, Oakland, CA 94115, USA
    Pediatr Infect Dis J 17:980-5. 1998
    ..Local and systemic adverse reactions were recorded. Exposure and cases of varicella were documented through a 1-year follow-up period...
  83. ncbi Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine
    Terry Nolan
    The University of Melbourne, Department of Paediatrics, and Murdoch Children s Research Institute at the Royal Children s Hospital, Melbourne, Australia
    Vaccine 21:281-9. 2002
    ..This tetravalent MMRV candidate vaccine showed promising results, although further examination of the possible increase in minor fever and decreased varicella immunogenicity should be assessed in future studies...
  84. ncbi Delays in receipt of immunizations in low-birth-weight children: a nationally representative sample
    D L Langkamp
    Children s Hospital, Room H310, 700 Children s Dr, Columbus, OH 43205, USA
    Arch Pediatr Adolesc Med 155:167-72. 2001
    ..However, a recent study of VLBW children in 3 health maintenance organizations found no significant delays in immunizations...
  85. ncbi Population-based study of the adequacy of well-child care services: a rural county's report card
    A M Gadomski
    Research Institute, Mary Imogene Bassett Hospital, Cooperstown, NY, USA
    Arch Pediatr Adolesc Med 152:745-8. 1998
    ..To determine the adequacy of well-child care services using a population-based study...
  86. ncbi Assessing immunization performance of private practitioners in Maine: impact of the assessment, feedback, incentives, and exchange strategy
    M S Massoudi
    Centers for Disease Control and Prevention, National Immunization Program, Atlanta, Georgia, USA
    Pediatrics 103:1218-23. 1999
    ..The Maine Immunization Program, and the Maine Chapter of the American Academy of Pediatrics collaborated on the implementation and evaluation of this strategy among private providers...
  87. ncbi Rubella outbreak in the Netherlands, 2004-2005: high burden of congenital infection and spread to Canada
    Susan Hahne
    Centre for Infectious Disease Control, National Institute for Public Health and the Environment RIVM, The Netherlands
    Pediatr Infect Dis J 28:795-800. 2009
    ..In The Netherlands and Canada the measles, mumps, rubella vaccine coverage is high. In 2004 a rubella outbreak started in the Netherlands in a population subgroup with low coverage, with subsequent spread to Canada...
  88. ncbi Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella
    Keri Wellington
    Adis International Limited, Mairangi Bay, Auckland, New Zealand
    Drugs 63:2107-26. 2003
    ..Furthermore, GSK-MMR causes fewer injection-site adverse events than Merck-MMR. As such, GSK-MMR is an attractive alternative for immunisation against measles, mumps and rubella...
  89. ncbi Associations between childhood vaccination coverage, insurance type, and breaks in health insurance coverage
    Philip J Smith
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Pediatrics 117:1972-8. 2006
    ..This study explored how vaccination coverage is associated with not being insured and with insurance type among children who are insured and to show how these associations are modified by race/ethnicity...
  90. ncbi Sero-response to measles-mumps-rubella vaccine campaign in Saudi Arabia
    Yagob Y Al-Mazrou
    Department of Preventive Medicine, Ministry of Health, Qassim, Kingdom of Saudi Arabia
    Saudi Med J 23:680-3. 2002
    ..To evaluate the measles-mumps-rubella vaccine campaign targeting primary school children in the Kingdom of Saudi Arabia during the months of January and February 2000...
  91. ncbi Vaccinations and risk of central nervous system demyelinating diseases in adults
    Frank Destefano
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Arch Neurol 60:504-9. 2003
    ..Several case reports of the onset or exacerbation of multiple sclerosis or other demyelinating conditions shortly after vaccination have suggested that vaccines may increase the risk of demyelinating diseases...
  92. ncbi Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubella vaccination in children treated for acute lymphoblastic leukemia
    Tugba Erener Ercan
    Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey
    J Pediatr Hematol Oncol 27:273-7. 2005
    ..Children with ALL can receive the appropriate vaccines during and after maintenance treatment...
  93. ncbi Measles vaccination and inflammatory bowel disease: controversy laid to rest?
    R L Davis
    Department of Paediatrics, University of Washington School of Medicine, Seattle, Washington 98103, USA
    Drug Saf 24:939-46. 2001
    ....
  94. ncbi CHIP shots: association between the State Children's Health Insurance Programs and immunization rates
    Ted Joyce
    Department of Economics, Baruch College, City University of New York, New York, USA
    Pediatrics 115:e526-34. 2005
    ..The objective of this study was to use data from the National Immunization Survey from 1995 to 2002 to analyze changes in immunization coverage rates among poor, near-poor, and nonpoor children before and after implementation of SCHIP...
  95. ncbi Measles outbreak in Japan: Why now?
    Kanako Masuno
    Biosci Trends 1:3. 2007
  96. ncbi HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine
    Inna G Ovsyannikova
    Mayo Vaccine Research Group, Mayo Clinic and Foundation, Guggenheim 611C, 200 1st Street SW, Rochester, MN 55905, USA
    Immunogenetics 56:798-807. 2005
    ..These data suggest that IFN-gamma and IL-4 cytokine responses to measles may be genetically restricted in part by HLA class II genes, which in turn can restrict the cellular immune response to measles vaccine...
  97. ncbi Effectiveness of a vaccination program against mumps in Ukraine
    Y Hrynash
    Department of Pediatric Infectious Diseases, Lviv National Medical University, 69 Pekarska St, 79010, Lviv, Ukraine
    Eur J Clin Microbiol Infect Dis 27:1171-6. 2008
    ..The use of vaccine with a derivate of the Jeryl Lynn strain has resulted in a dramatic drop in mumps cases since 2002...
  98. ncbi Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age
    M Ceyhan
    Division of Pediatric Infectious Diseases, Hacettepe University School of Medicine, 06100, Ankara, Turkey
    Vaccine 19:4473-8. 2001
    ..All children had been followed for occurrence of measles infection for 60 months. Two vaccination schedules were compared for immunogenicity and protection rates...
  99. ncbi Childhood vaccination and nontargeted infectious disease hospitalization
    Anders Hviid
    Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark
    JAMA 294:699-705. 2005
    ....
  100. ncbi Adolescent vaccination: coverage achieved by ages 13-15 years, and vaccinations received as recommended during ages 11-12 years, National Health Interview Survey 1997-2003
    Mary Mason McCauley
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Adolesc Health 43:540-7. 2008
    ..To present progress toward Healthy People 2010 vaccination objectives for adolescents aged 13-15 years, and to determine how much catch-up and routine vaccination was administered at the recommended ages of 11-12 years...
  101. ncbi Vaccination status of children in the Women, Infants, and Children (WIC) Program: are we doing enough to improve coverage?
    A M Shefer
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Am J Prev Med 20:47-54. 2001
    ..Vaccination-promoting strategies in the Supplemental Nutrition Program for Women, Infants, and Children (WIC) have been shown to produce dramatic improvements in coverage and other health outcomes...

Research Grants16

  1. Short Tandem Repeat Polymorphisms in Cytomegalovirus
    James Bale; Fiscal Year: 2003
    ..Characterizing HCM' strains by STR analysis will facilitate future studies of HCMV evolution and will provide a novel means t to fingerprint HCMV strains. ..
  2. Trainee-Focusted Training for Research Integrity
    Steven Jacobsen; Fiscal Year: 2003
    ..6. Identify high frequency perceptions or frames of reference, which are substantially at odds with accepted research norms and begin designing better interventions to alter them. ..
  3. ENHANCING MUCOSAL IMMUNE RESPONSES BY MICROENCAPSULATION
    Paul Offit; Fiscal Year: 2005
    ..The availability of microencapsulated virus provides a unique opportunity to understand the relationship between APC and protective mucosal immune responses. ..
  4. Study of risk factors of tick-borne encephalitis in Poland
    Pawel Stefanoff; Fiscal Year: 2009
    ....
  5. DETERMINING/UNDERSTANDING BARRIERS TO ADULT IMMUNIZATION
    Richard Zimmerman; Fiscal Year: 2001
    ..This project will furnish relevant, up-to-date to enhance policy planning, practice management and medical education. ..
  6. Using MEPS Data to Inform Public-Plan Consumerism
    Matthew Davis; Fiscal Year: 2007
    ..Findings will have immediate relevance for implementation of the HOA projects and other consumerism efforts. [unreadable] [unreadable] [unreadable]..
  7. Parental Involvement Laws and Reproductive Outcomes
    Theodore Joyce; Fiscal Year: 2006
    ..Teens who do not involve their parents may take longer to obtain an abortion either out of state or through a judicial bypass. Thus, we expect PI laws to increase the rate of second trimester abortions among minors. ..
  8. Parent Initiated Prevention Program
    Dimitri Christakis; Fiscal Year: 2005
    ..3) To improve parental perceptions of the quality of care provided.H3: Compared to controls, PIPP parents will report higher scores on selected Consumer Assessment of Health Plans (CAHPS) items. ..
  9. UNSTUDIED INFANTS: LOW RISK BABIES IN A HIGH RISK PLACE
    Marie McCormick; Fiscal Year: 2002
    ..Results will identify sites with better outcomes and the practices associated with them. These outcomes represent achievable goals well within the scope of current technology. ..
  10. Internet Based Patient-Centered Asthma Management System
    Dimitri Christakis; Fiscal Year: 2009
    ..Children in AsthmaNet families will be more likely to report using written care plans. Aim 4: to decrease the number of symptom days for children with asthma H4. Children in AsthmaNet families will experience fewer symptom days. ..
  11. VZV Receptors and Infective Mechanisms
    Anne Gershon; Fiscal Year: 2007
    ..It may also make it possible to develop a safer and more efficacious vaccine. ..
  12. MOLECULAR APPROACHES TO CHILDHOOD PSYCHIATRIC DISORDERS
    Matthew State; Fiscal Year: 2006
    ..abstract_text> ..
  13. The Role of SLITRK1 in Tourette and Related Disorders
    Matthew W State; Fiscal Year: 2010
    ..The purpose of this study is to better understand .what causes TD by identifying additional abnormalities in the SLITRK1 gene and by investigating the impact of these unusual genetic changes on the developing brain. ..
  14. PEDIATRICS AIDS CLINICAL TRIALS GROUP
    Anne Gershon; Fiscal Year: 2006
    ..We have competent, outstanding staff whose aim is not only to provide compassionate medical care to HIV-infected patients but also to perform meaningful and useful research on prevention and treatment of HIV infection. ..
  15. Molecular Cytogenetics and Tourette Disorder
    Matthew State; Fiscal Year: 2006
    ..abstract_text> ..